Genome-Wide Association Study for Circulating Tissue Plasminogen Activator Levels and Functional Follow-Up Implicates Endothelial STXBP 5 and STX 2
Jie Huang,J. Huffman,M. Yamakuchi,S. Trompet,F. Asselbergs,M. Sabater-Lleal,D. Trégouët,Wei-Min Chen,N. Smith,M. Kleber,S. Shin,D. Becker,Weihong Tang,A. Dehghan,Andrew D. Johnson,V. Truong,L. Folkersen,Qiong Yang,Tiphaine Oudot-Mellkah,B. Buckley,J. Moore,F. Williams,H. Campbell,G. Silbernagel,V. Vitart,I. Rudan,G. Tofler,G. Navis,A. Destefano,A. Wright,Ming-Huei Chen,A. Craen,B. Worrall,A. Rudnicka,A. Rumley,E. Bookman,B. Psaty,Fang Chen,Keith L. Keene,O. Franco,B. Böhm,A. Uitterlinden,A. Carter,J. Jukema,N. Sattar,J. Bis,M. Ikram,B. McKnight,K. Taylor,P. Slagboom,W. McArdle,F. Hsu,A. Franco-Cereceda,A. Goodall,L. Yanek,A. Hofman,J. Witteman,A. Folsom,S. Basu,N. Matijevic,W. H. Gilst,James F. Wilson,S. Kathiresan,O. Polašek,B. Winkelmann,P. Grant,H. Hillege,F. Cambien,D. Stott,G. Lowe,T. Spector,J. Meigs,W. Marz,P. Eriksson,L. Becker,P. Morange,N. Soranzo,Scott M. Williams,C. Hayward,A. Hamsten,C. Lowenstein,D. Strachan,C. O’Donnell
2014-01-01
Abstract:Objective—Tissue plasminogen activator (tPA), a serine protease, catalyzes the conversion of plasminogen to plasmin, the major enzyme responsible for endogenous fibrinolysis. In some populations, elevated plasma levels of tPA have been associated with myocardial infarction and other cardiovascular diseases. We conducted a meta-analysis of genome-wide association studies to identify novel correlates of circulating levels of tPA. Approach and Results—Fourteen cohort studies with tPA measures (N=26 929) contributed to the meta-analysis. Three loci were significantly associated with circulating tPA levels (P<5.0×10 −8). The first locus is on 6q24.3, with the lead single nucleotide polymorphism (SNP; rs9399599; P=2.9×10 −14) within STXBP5. The second locus is on 8p11.21. The lead SNP (rs3136739; P=1.3×10 −9) is intronic to POLB and <200 kb away from the tPA encoding the gene PLAT. We identified a nonsynonymous SNP (rs2020921) in modest linkage disequilibrium with rs3136739 (r 2 =0.50) within exon 5 of PLAT (P=2.0×10 −8). The third locus is on 12q24.33, with the lead SNP (rs7301826; P=1.0×10 −9) within intron 7 of STX2. We further found evidence for the association of lead SNPs in STXBP5 and STX2 with expression levels of the respective transcripts. In in vitro cell studies, silencing STXBP5 decreased the release of tPA from vascular endothelial cells, whereas silencing STX2 increased the tPA release. Through an in silico lookup, we found no associations of the 3 lead SNPs with coronary artery disease or stroke. Conclusions—We identified 3 loci associated with circulating tPA levels, the PLAT region, STXBP5, and STX2. Our functional studies implicate a novel role for STXBP5 and STX2 in regulating tPA release. Key Words: fibrinolysis ◼ genome-wide association study ◼ hemostasis ◼ meta-analysis ◼ tissue plasminogen activator Nonstandard Abbreviations and Acronyms CAD coronary artery disease CVD cardiovascular disease eQTL expression quantitative trait locus eSNP expression single nucleotide polymorphism GWAS genome-wide association study LD linkage disequilibrium tPA tissue plasminogen activator vWF von Willebrand factor T issue plasminogen activator (tPA) is a glycoprotein produced mainly by vascular endothelial cells that catalyzes the conversion of plasminogen to plasmin, the major enzyme responsible for endogenous fibrinolysis and an important regulatory element in thrombosis. Circulating tPA is implicated in the progression and incidence of clinically apparent atherothrombotic cardiovascular diseases (CVDs), such as myocardial infarction and stroke, and is associated, in some studies, with advanced atherosclerosis. Recombinant tPA is approved for use in patients with acute myocardial infarc-tion and is the only drug approved by the US Food …